NCT02734433 2022-04-25Study of Pexidartinib in Asian Subjects With Advanced Solid TumorsDaiichi SankyoPhase 1 Completed12 enrolled 22 charts
NCT01004861 2022-01-04Safety Study of PLX108-01 in Patients With Solid TumorsDaiichi SankyoPhase 1 Completed132 enrolled 28 charts
NCT03291288 2021-05-14Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)Daiichi SankyoPhase 1 Completed32 enrolled 22 charts